scispace - formally typeset
Open AccessJournal ArticleDOI

Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE)

Reads0
Chats0
TLDR
This study examined the selectivity of commonly used pharmacological inhibitors of H2S biosynthesis towards CSE and CBS.
Abstract
Background and Purpose Hydrogen sulfide (H2S) is a signalling molecule that belongs to the gasotransmitter family. Two major sources for endogenous enzymatic production of H2S are cystathionine β synthase (CBS) and cystathionine γ lyase (CSE). In the present study, we examined the selectivity of commonly used pharmacological inhibitors of H2S biosynthesis towards CSE and CBS. Experimental Approach To address this question, human CSE or CBS enzymes were expressed and purified from Escherichia coli as fusion proteins with GSH-S-transferase. After purification, the activity of the recombinant enzymes was tested using the methylene blue method. Key Results β-cyanoalanine (BCA) was more potent in inhibiting CSE than propargylglycine (PAG) (IC50 14 ± 0.2 μM vs. 40 ± 8 μM respectively). Similar to PAG, L-aminoethoxyvinylglycine (AVG) only inhibited CSE, but did so at much lower concentrations. On the other hand, aminooxyacetic acid (AOAA), a frequently used CBS inhibitor, was more potent in inhibiting CSE compared with BCA and PAG (IC50 1.1 ± 0.1 μM); the IC50 for AOAA for inhibiting CBS was 8.5 ± 0.7 μM. In line with our biochemical observations, relaxation to L-cysteine was blocked by AOAA in aortic rings that lacked CBS expression. Trifluoroalanine and hydroxylamine, two compounds that have also been used to block H2S biosynthesis, blocked the activity of CBS and CSE. Trifluoroalanine had a fourfold lower IC50 for CBS versus CSE, while hydroxylamine was 60-fold more selective against CSE. Conclusions and Implications In conclusion, although PAG, AVG and BCA exhibit selectivity in inhibiting CSE versus CBS, no selective pharmacological CBS inhibitor is currently available.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Chemical Biology of H2S Signaling through Persulfidation.

TL;DR: The biologically relevant chemistry of H2S and the enzymatic routes for its production and oxidation are discussed and the roles ascribed to protein persulfidation in cell signaling pathways are discussed.
Journal ArticleDOI

Gasotransmitters in cancer: from pathophysiology to experimental therapy

TL;DR: The role of each gasotransmitter in cancer and the effects of pharmacological agents — some of which are in early-stage clinical studies — that modulate the levels of eachGasotransmitters are discussed.
Journal ArticleDOI

A review of hydrogen sulfide (H2S) donors: Chemistry and potential therapeutic applications.

TL;DR: This review examines a variety of H2S donor systems classified by their H 2S‐releasing trigger as well as their H1N1 release profiles, byproducts, and potential therapeutic applications.
Journal ArticleDOI

International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

TL;DR: The present article overviews the currently known H 2S donors and H2S biosynthesis inhibitors, delineates their mode of action, and offers examples for their biologic effects and potential therapeutic utility.
Journal ArticleDOI

A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?

TL;DR: A bell-shaped model has been proposed to explain the role of H2S in cancer development and indicates that inhibition of H1N1 biosynthesis and H1S supplementation serve as two distinct ways for cancer treatment.
References
More filters
Journal ArticleDOI

Animal research: reporting in vivo experiments: the ARRIVE guidelines

TL;DR: An accurate summary of the background, research objectives, including details of the species or strain of animal used, key methods, principal findings and conclusions of the study is provided.
Journal ArticleDOI

Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines:

TL;DR: The following guidelines are excerpted (as permitted under the Creative Commons Attribution License (CCAL), with the knowledge and approval of PLoS Biology and the authors) from Kilkenny et al.
Journal ArticleDOI

Hydrogen sulphide and its therapeutic potential

TL;DR: The physiology and biochemistry of H2S is overviews, the effects of H 2S inhibitors or H2s donors in animal models of disease are summarized, the potential options for the therapeutic exploitation of H1S are outlined and they are outlined.
Journal ArticleDOI

Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed

TL;DR: The important life-supporting role of hydrogen sulfide (H(2)S) has evolved from bacteria to plants, invertebrates, vertebrate, vertebrates, and finally to mammals, but over the centuries it had only been known for its toxicity and environmental hazard.
Journal ArticleDOI

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

TL;DR: An editorial summarizes the background to the ‘ARRIVE’ guidelines, gives the view of their significance, considers aspects of specific relevance to pharmacology, re‐states BJP's guidelines for authors on animal experiments and indicates the commitment to carrying on discussion of this important topic.
Related Papers (5)